Adam Mor

7PUBLICATIONS
22CO-AUTHORS
Tumour immunologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Carbon capture engineering (excl. sequestration)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2026
Cardiac tertiary immune niches drive immune activation in immune checkpoint inhibitor myocarditis.

|Mar 08, 2024
Transmembrane domain-driven PD-1 dimers mediate T cell inhibition.

Elliot A Philips, Jia Liu, Audun Kvalvaag

|Feb 11, 2021
A novel mouse model for checkpoint inhibitor-induced adverse events.

Kieran Adam, Alina Iuga, Anna S Tocheva

|Dec 29, 2019
The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals.

Elliot A Philips, Antonio Garcia-España, Anna S Tocheva

|Dec 24, 2019
PLCε1 suppresses tumor growth by regulating murine T cell mobilization.

M Strazza, K Adam, A V Smrcka

|Sep 13, 2018
Proteomic analysis of human T cell-derived exosomes reveals differential RAS/MAPK signaling.

Inbar Azoulay-Alfaguter, Adam Mor

Pageof 2

Frequent Collaborators

2 joint publications

Inbar Azoulay-Alfaguter

1 joint publications

Hila K Novak

1 joint publications

James Muller

1 joint publications

Elliot A Philips